Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.
Brotherhood has a sizeable cast of characters all of different nationalities and ... familial trauma hits like a truck. Based on the best-selling shoujo manga from Natsuki Takaya, the story ...
While some vague timing guidelines do exist, the best time to ... The rationale for selling during this time frame is that most stocks that have been actively trading all day may have already ...
Apple’s iPhone 14 Pro Max is the top-of-the-line product in the iPhone ... and a 12MP f/2.2 ultrawide sensor. A ToF (Time-of-Flight) 3D LiDAR scanner is also available for depth tracking.